Kuehne + Nagel and the pharmaceutical research company, Grünenthal Group, agree global partnership for land, air and sea freight. In addition to the conceptual development of the network, the agreement involves integrated logistics services such as network and stock management and the global transportation of temperature-controlled products by sea, air and land.
Grünenthal has production sites in Europe and Latin America and through its subsidiaries is represented in 32 countries. In order to supply all its sites, Grünenthal was looking for a partner that could operate on a global scale who meets the company’s demands in terms of reliability and traceability of the delivery.
Kuehne + Nagel and Grünenthal are working together to develop a solution that is tailored to the requirements of the Grünenthal Group with KN PharmaChain as its core element. KN PharmaChain is a multi-modal logistics solution for temperature-controlled door-to-door transportation which allows accurate traceability of the deliveries and intensive, proactive risk management.
Victor Barbosa, Senior Vice President Global Supply Chain Grünenthal, explained: “With this new agreement, we were able to combine all our global forwarding services with the Kuehne + Nagel Group. This centralisation and our partner’s expertise in the pharmaceutical industry will help us to make our processes more efficient and enhance our competitiveness”.
Hansjörg Rodi, Managing Director Kuehne + Nagel Germany, added: “We are delighted with the confidence the Grünenthal Group has placed in us and look forward to future collaboration. Our aim is to reshape the entire network for logistics services together with the customer. To achieve this, we will utilise our expertise in providing services for the pharmaceutical and healthcare industry, which is of strategic importance for Kuehne + Nagel”.
Source: Kuehne + Nagel